PHIC PHILHEALTH CIRCULAR NO. 018, s. 2000 ADDITIONAL DRUGS FOR INCLUSION TO THE PRESENT LIST OF PHIC REIMBURSABLE DRUGS June 15, 2000

The Philippine National Drug Formulary (PNDF), the main reference of PhilHealth for drug reimbursement, has been recently revised and updated by the Department of Health.

The following drugs which are newly listed in the 5th edition (latest edition) of the PNDF are now reimbursable effective May 30, 2000.

Ibuprofen	Risperidone
Codeine	Cinnarizine
Esmolol	Meclozine (Meclizine)
Gabapentin	Celecoxib
Pergolide	Etodolac
Ibuprofen	Ketoprofen
Zolpidem	Rocuronium
Fluoxetine	Mivacurium
Sertraline	Indometacin
Carbamazepine	Azathioprine
Valproate disodium	Ciclosporin
Cyclophosphamide	Zalcitabine
Hydroxychloroquine	Hemophilus Influenzae (Hib)
Meropenem	Conjugal Vaccine
Cefepime	DTP + hepatitis B vaccine
Azithromycin	DTP + Hib
Piperacillin + Tazobactam	DTP + IPV + Hib
Nalidixic Acid	Hepatitis A vaccine
Amoxicillin	Influenza Polyvalent Vaccine
Clarithromycin	Carvedilol (cardioselectiv/no ISA)
Metronidazole	Amlodipine
Minocycline	Nimodipine
Amikacin	Irbesartan
Isoniazid + Ethambutol	Losartan
Isoniazid + Rifampicin	Simvastatin
Isoniazid + Rifampicin +	Dipyridamole
	Pyrazinamide	Cetirizine
Isoniazid + Rifampicin +	Daunorubicin
	Pyrazinamide + Ethambutol	Idarubicin
Ofloxacin	Mitoxantrone
Terizodone	Tegafur + uracil
Amphotericin B	Antilymphocyte Immunoglobulin (ALG-equine)
Famciclovir	Antithymocyte Immunoglobulin (ATG-rabbit)
Lamivudine	Mycophenolate mofetil
Indinavir
Ritonavir
Saquinavir
Valaciclovir

Please be guided accordingly.

Adopted: 15 June 2000

(SGD.) ENRIQUE M. ZALAMEA
President and CEO